FDA Clearance Tracker · K222829
Curian® Shiga Toxin
Last checked: Nov 19, 2026Latest source record: Apr 17, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Apr 17, 2023
Substantially Equivalent
Time to decision
210 days
Received Sep 19, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K222829
- Device name
- Curian® Shiga Toxin
- Applicant
- Meridian Bioscience, Inc.
- Applicant location
- Cincinnati, OH
- Received
- Sep 19, 2022
- Decided
- Apr 17, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Antigens, All Types, Escherichia Coli (GMZ)
- Device class
- Class I
- Regulation
- 21 CFR 866.3255
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GMZ. The earliest in FDA's data is K884513, decided Feb 3, 1989.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K222829
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Meridian Bioscience, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Revogene510(k)
K243922 · Decided Mar 20, 2025 · 90 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
K230901 · Decided Jul 3, 2023 · 94 days after receipt
Device type: Helicobacter Pylori (LYR) · Laboratory Medicine & Pathology
- Revogene510(k)
K222779 · Decided Jan 26, 2023 · 134 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.